UNSPSC 51112501: Ambamustine

This classification denotes a nitrogen mustard compound with the molecular formula C29H39Cl2FN4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IB1H345F24, chemically known as n-(3-(m-(bis(2-chloroethyl)amino)phenyl)-n-(3-(p-fluorophenyl)-l-alanyl)-l-alanyl)-l-methionine, ethyl ester but more generally known as ambamustine, which bears US NIH Compound Identifier 178137. Ambamustine most often comes in base and hydrochloride forms.

UNSPSC 51112501 Ambamustine is a Commodity code for a specialized pharmaceutical compound. State and local governments procure ambamustine almost exclusively through their healthcare and correctional-facility pharmacy operations, typically as part of broader chemotherapy drug formularies or emergency medical stockpile acquisitions. The drug is sourced via state health department procurement, county hospital systems, and correctional health services rather than through general government supply channels. Purchasing patterns reflect clinical demand within inpatient and specialty-care settings, and procurement volumes and frequency depend on patient population size and treatment protocols at each institution.

No recent state and local contract opportunities for ambamustine appear in the available records. The Commodity code shows minimal procurement activity in the current market, likely reflecting the narrow clinical indication for the drug and the dominance of established vendor relationships within healthcare procurement networks. Organizations interested in pursuing this code should monitor state health department and county hospital system RFPs for oncology formulary contracts, as ambamustine procurement is typically embedded within broader pharmaceutical supply agreements rather than solicited as a standalone item.